KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$0.05
-0.01 (-8.65%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+89,408.2% upside
Low Target
$31.72
Average Target
$49.14
High Target
$61.64
Current Price
$0.05
Current
$0.05
$0.05
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Scenario Analysis
Bear Case
$31.72
57,677.8%
Low target
Base Case
$49.14
+89,408.2%
Avg target
Bull Case
$61.64
+112,176.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$49.14
+347.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |